Coronado Gloria D, Petrik Amanda F, Vollmer William M, Taplin Stephen H, Keast Erin M, Fields Scott, Green Beverly B
Kaiser Permanente Center for Health Research, Portland, Oregon.
Center for Global Health, National Cancer Institute, Rockville, Maryland.
JAMA Intern Med. 2018 Sep 1;178(9):1174-1181. doi: 10.1001/jamainternmed.2018.3629.
Approximately 24 million US individuals receive care at federally qualified health centers, which historically have low rates of colorectal cancer screening. The US Preventive Services Task Force recommends routine colorectal cancer screening for individuals aged 50 to 75 years.
To determine the effectiveness of an electronic health record (EHR)-embedded mailed fecal immunochemical test (FIT) outreach program implemented in health centers as part of standard care.
DESIGN, SETTING, AND PARTICIPANTS: This cluster randomized pragmatic clinical trial was conducted in 26 federally qualified health center clinics, representing 8 health centers in Oregon and California, randomized to intervention (n = 13) or usual care (n = 13). All participants were overdue for colorectal cancer screening during the accrual interval (February 4, 2014 to February 3, 2015).
Electronic health record-embedded tools to identify eligible adults and to facilitate implementation of a stepwise mailed intervention involving (1) an introductory letter, (2) a mailed FIT, and (3) a reminder letter; training, collaborative learning, and facilitation through a practice improvement process.
Effectiveness was measured as clinic-level proportions of adults who completed a FIT, and secondarily, any colorectal cancer screening within 12 months of accrual or by August 3, 2015. Implementation was measured as clinic-level proportions of adults who were mailed an introductory letter and ordered a FIT.
Twenty-six clinics with 41 193 adults (mean [SD] age, 58.5 [6.3] years; 22 994 women) were randomized to receive the direct mail colorectal screening intervention (13 clinics; 21 134 patients) or usual care (13 clinics; 20 059 patients). Compared with usual care clinics, intervention clinics had significantly higher adjusted clinic-level proportion of participants who completed a FIT (13.9% vs 10.4%; difference, 3.4 percentage points; 95% CI, 0.1%-6.8%) and any colorectal cancer screening (18.3% vs 14.5%; difference, 3.8 percentage points; 95% CI, 0.6%-7.0%). We observed large variation across health centers in effectiveness (FIT completion differences range, -7.4 percentage points to 17.6 percentage points) and implementation (proportion who were mailed a FIT range, 6.5% to 68.2%). The number needed to mail to achieve a completed FIT was 4.8 overall, and 4.0 in clinics that mailed a FIT reminder.
An EHR-embedded mailed FIT outreach intervention significantly improved rates of FIT completion and rates of any colorectal cancer screening. Higher rates of colorectal cancer screening occurred in clinics that successfully implemented the mailed outreach program.
ClinicalTrials.gov identifier: NCT01742065.
约2400万美国民众在联邦合格健康中心接受治疗,而这些中心历来的结直肠癌筛查率较低。美国预防服务工作组建议对50至75岁的人群进行常规结直肠癌筛查。
确定作为标准护理一部分在健康中心实施的嵌入电子健康记录(EHR)的邮寄粪便免疫化学检测(FIT)推广计划的有效性。
设计、设置和参与者:这项整群随机实用临床试验在26家联邦合格健康中心诊所进行,这些诊所代表俄勒冈州和加利福尼亚州的8家健康中心,随机分为干预组(n = 13)或常规护理组(n = 13)。所有参与者在纳入期(2014年2月4日至2015年2月3日)均 overdue for 结直肠癌筛查。
嵌入电子健康记录的工具,用于识别符合条件的成年人,并促进实施逐步邮寄干预措施,包括(1)一封介绍信,(2)一份邮寄的FIT,以及(3)一封提醒信;通过实践改进过程进行培训、协作学习和促进。
有效性以完成FIT的成年人的诊所层面比例来衡量,其次是以纳入期12个月内或2015年8月3日前进行任何结直肠癌筛查的比例来衡量。实施情况以收到介绍信并订购FIT的成年人的诊所层面比例来衡量。
26家诊所的41193名成年人(平均[标准差]年龄为58.5[6.3]岁;22994名女性)被随机分配接受直接邮寄结直肠癌筛查干预(13家诊所;21134名患者)或常规护理(13家诊所;20059名患者)。与常规护理诊所相比,干预诊所完成FIT的参与者的调整后诊所层面比例显著更高(13.9%对10.4%;差异为3.4个百分点;95%置信区间为0.1%-6.8%),以及进行任何结直肠癌筛查的比例也更高(18.3%对14.5%;差异为3.8个百分点;95%置信区间为0.6%-7.0%)。我们观察到各健康中心在有效性(FIT完成差异范围为-7.4个百分点至17.6个百分点)和实施情况(收到FIT邮寄的比例范围为6.5%至68.2%)方面存在很大差异。总体而言,实现一次完成的FIT所需邮寄的数量为4.8封,在邮寄FIT提醒的诊所中为4.0封。
嵌入EHR的邮寄FIT推广干预显著提高了FIT完成率和任何结直肠癌筛查率。在成功实施邮寄推广计划的诊所中,结直肠癌筛查率更高。
ClinicalTrials.gov标识符:NCT01742065 。